1. Home
  2. VTEX vs CDNA Comparison

VTEX vs CDNA Comparison

Compare VTEX & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTEX
  • CDNA
  • Stock Information
  • Founded
  • VTEX 1999
  • CDNA 1998
  • Country
  • VTEX United Kingdom
  • CDNA United States
  • Employees
  • VTEX N/A
  • CDNA N/A
  • Industry
  • VTEX Computer Software: Prepackaged Software
  • CDNA Medical Specialities
  • Sector
  • VTEX Technology
  • CDNA Health Care
  • Exchange
  • VTEX Nasdaq
  • CDNA Nasdaq
  • Market Cap
  • VTEX 1.1B
  • CDNA 1.1B
  • IPO Year
  • VTEX 2021
  • CDNA 2014
  • Fundamental
  • Price
  • VTEX $6.01
  • CDNA $21.44
  • Analyst Decision
  • VTEX Strong Buy
  • CDNA Buy
  • Analyst Count
  • VTEX 5
  • CDNA 8
  • Target Price
  • VTEX $10.20
  • CDNA $26.43
  • AVG Volume (30 Days)
  • VTEX 700.5K
  • CDNA 851.0K
  • Earning Date
  • VTEX 02-25-2025
  • CDNA 02-26-2025
  • Dividend Yield
  • VTEX N/A
  • CDNA N/A
  • EPS Growth
  • VTEX N/A
  • CDNA N/A
  • EPS
  • VTEX 0.05
  • CDNA N/A
  • Revenue
  • VTEX $225,906,000.00
  • CDNA $312,775,000.00
  • Revenue This Year
  • VTEX $17.08
  • CDNA $19.85
  • Revenue Next Year
  • VTEX $18.48
  • CDNA $11.34
  • P/E Ratio
  • VTEX $126.79
  • CDNA N/A
  • Revenue Growth
  • VTEX 21.27
  • CDNA 5.26
  • 52 Week Low
  • VTEX $5.60
  • CDNA $7.42
  • 52 Week High
  • VTEX $9.59
  • CDNA $34.84
  • Technical
  • Relative Strength Index (RSI)
  • VTEX 49.07
  • CDNA 43.79
  • Support Level
  • VTEX $5.97
  • CDNA $21.09
  • Resistance Level
  • VTEX $6.19
  • CDNA $25.95
  • Average True Range (ATR)
  • VTEX 0.17
  • CDNA 1.61
  • MACD
  • VTEX 0.04
  • CDNA 0.02
  • Stochastic Oscillator
  • VTEX 68.64
  • CDNA 19.46

About VTEX VTEX

Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

Share on Social Networks: